Chita, Japan

Shinya Fujiwara

This inventor holds 1 USPTO granted patent. Top assignee: Pfizer Corporation. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shinya Fujiwara. Retrieved from https://idiyas.com/inventor/shinya-fujiwara-74np25mq

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shinya Fujiwara: Innovator in Indole Compounds

Introduction

Shinya Fujiwara is a notable inventor based in Chita-gun, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as COX-2 inhibitors. His work is essential in advancing medical treatments and improving patient outcomes.

Latest Patents

Shinya Fujiwara holds a patent for indole compounds that act as COX-2 inhibitors. This invention provides a compound of a specific formula that has potential therapeutic applications. His innovative approach to drug design showcases his expertise and commitment to enhancing healthcare solutions.

Career Highlights

Fujiwara is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His role at Pfizer allows him to collaborate with other talented professionals in the industry, contributing to groundbreaking research and development efforts.

Collaborations

Some of his notable coworkers include Rodney W. Stevens and Kasumari Nakao. Their collective expertise fosters a collaborative environment that drives innovation and enhances the quality of their research.

Conclusion

Shinya Fujiwara's contributions to the field of pharmaceuticals, particularly through his patent on indole compounds, highlight his role as an influential inventor. His work at Pfizer Corporation and collaborations with esteemed colleagues further emphasize his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…